Analysis of mode of action of some nicotinic blocking drugs.
D000818:Animals; D002714:Chlorisondamine / Q000494:pharmacology; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006168:Guinea Pigs; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007700:Kinetics; D008464:Mecamylamine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology; D010393:Pempidine / Q000494:pharmacology; D010425:Pentolinium Tartrate / Q000494:pharmacology; D011817:Rabbits; D013757:Tetraethylammonium Compounds / Q000494:pharmacology
D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D013757:Tetraethylammonium Compounds; D004246:Dimethylphenylpiperazinium Iodide; D008464:Mecamylamine; D009538:Nicotine; D010425:Pentolinium Tartrate; D002714:Chlorisondamine; D010393:Pempidine